Ahuja Sana; Khan Adil Aziz; G Kiruthikasri; Zaheer Sufian
(Korean Society of Surgical Oncology, 2024-12)
Purpose: Breast cancer subtypes are delineated by human epidermal growth factor receptor 2 (HER2) expression, pivotal in treatment selection. HER2-positive tumors typically respond to targeted therapies, whereas HER2-negative ...